Further studies confirmed that luteolin inhibits Toll-like receptor 4 (TLR4)/NF-κB signaling and downstream pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in LPS-induced ALI models (Mi et al., 2024; Zou et al., 2021). This evidence concerns the gene TLR4 and acute respiratory distress syndrome.